Silverfin false false 31/10/2024 01/11/2023 31/10/2024 Dr G Cox 04/10/2011 24 July 2025 The principal activity of the company continued to be that of providing medicolegal services. 07796545 2024-10-31 07796545 bus:Director1 2024-10-31 07796545 2023-10-31 07796545 core:CurrentFinancialInstruments 2024-10-31 07796545 core:CurrentFinancialInstruments 2023-10-31 07796545 core:ShareCapital 2024-10-31 07796545 core:ShareCapital 2023-10-31 07796545 core:RetainedEarningsAccumulatedLosses 2024-10-31 07796545 core:RetainedEarningsAccumulatedLosses 2023-10-31 07796545 core:LandBuildings 2023-10-31 07796545 core:PlantMachinery 2023-10-31 07796545 core:OfficeEquipment 2023-10-31 07796545 core:LandBuildings 2024-10-31 07796545 core:PlantMachinery 2024-10-31 07796545 core:OfficeEquipment 2024-10-31 07796545 core:CostValuation 2023-10-31 07796545 core:AdditionsToInvestments 2024-10-31 07796545 core:DisposalsRepaymentsInvestments 2024-10-31 07796545 core:RevaluationsIncreaseDecreaseInInvestments 2024-10-31 07796545 core:CostValuation 2024-10-31 07796545 bus:OrdinaryShareClass1 2024-10-31 07796545 bus:OrdinaryShareClass2 2024-10-31 07796545 bus:OrdinaryShareClass3 2024-10-31 07796545 bus:OrdinaryShareClass4 2024-10-31 07796545 2023-11-01 2024-10-31 07796545 bus:FilletedAccounts 2023-11-01 2024-10-31 07796545 bus:SmallEntities 2023-11-01 2024-10-31 07796545 bus:AuditExemptWithAccountantsReport 2023-11-01 2024-10-31 07796545 bus:PrivateLimitedCompanyLtd 2023-11-01 2024-10-31 07796545 bus:Director1 2023-11-01 2024-10-31 07796545 core:LandBuildings core:TopRangeValue 2023-11-01 2024-10-31 07796545 core:PlantMachinery core:TopRangeValue 2023-11-01 2024-10-31 07796545 core:OfficeEquipment 2023-11-01 2024-10-31 07796545 2022-11-01 2023-10-31 07796545 core:LandBuildings 2023-11-01 2024-10-31 07796545 core:PlantMachinery 2023-11-01 2024-10-31 07796545 bus:OrdinaryShareClass1 2023-11-01 2024-10-31 07796545 bus:OrdinaryShareClass1 2022-11-01 2023-10-31 07796545 bus:OrdinaryShareClass2 2023-11-01 2024-10-31 07796545 bus:OrdinaryShareClass2 2022-11-01 2023-10-31 07796545 bus:OrdinaryShareClass3 2023-11-01 2024-10-31 07796545 bus:OrdinaryShareClass3 2022-11-01 2023-10-31 07796545 bus:OrdinaryShareClass4 2023-11-01 2024-10-31 07796545 bus:OrdinaryShareClass4 2022-11-01 2023-10-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 07796545 (England and Wales)

GJC MEDICOLEGAL CONSULTING LTD.

UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 31 OCTOBER 2024
PAGES FOR FILING WITH THE REGISTRAR

GJC MEDICOLEGAL CONSULTING LTD.

UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 OCTOBER 2024

Contents

GJC MEDICOLEGAL CONSULTING LTD.

BALANCE SHEET

AS AT 31 OCTOBER 2024
GJC MEDICOLEGAL CONSULTING LTD.

BALANCE SHEET (continued)

AS AT 31 OCTOBER 2024
Note 2024 2023
£ £
Fixed assets
Tangible assets 4 229,972 233,052
Investments 5 304,206 196,264
534,178 429,316
Current assets
Debtors 6 889,439 1,300,691
Cash at bank and in hand 367,575 524,621
1,257,014 1,825,312
Creditors: amounts falling due within one year 7 ( 208,044) ( 532,221)
Net current assets 1,048,970 1,293,091
Total assets less current liabilities 1,583,148 1,722,407
Provision for liabilities ( 1,241) ( 1,498)
Net assets 1,581,907 1,720,909
Capital and reserves
Called-up share capital 8 4 4
Profit and loss account 1,581,903 1,720,905
Total shareholders' funds 1,581,907 1,720,909

For the financial year ending 31 October 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The financial statements of GJC Medicolegal Consulting Ltd. (registered number: 07796545) were approved and authorised for issue by the Director on 24 July 2025. They were signed on its behalf by:

Dr G Cox
Director
GJC MEDICOLEGAL CONSULTING LTD.

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 OCTOBER 2024
GJC MEDICOLEGAL CONSULTING LTD.

NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 OCTOBER 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

GJC Medicolegal Consulting Ltd. (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Beckfoot Hall, Appleby Road, Kirkby Stephen, CA17 4PG, United Kingdom. The principal place of business is Beckfoot Hall, Appleby Road, Kirkby Stephen, CA17 4PG, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include the fixed asset investments at fair value in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Foreign currency

Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the Balance Sheet date are reported at the rates of exchange prevailing at that date.

Exchange differences are recognised in the Profit and Loss Account in the period in which they arise except for exchange differences arising on gains or losses on non-monetary items which are recognised in the Statement of Comprehensive Income.

Turnover

Turnover is stated net of VAT and trade discounts and is recognised when the significant risks and rewards are considered to have been transferred to the buyer. Turnover from the supply of services represents the value of services provided under contracts to the extent that there is a right to consideration and is recorded at the fair value of the consideration received or receivable. Where a contract has only been partially completed at the Balance Sheet date turnover represents the fair value of the service provided to date based on the stage of completion of the contract activity at the Balance Sheet date. Where payments are received from customers in advance of services provided, the amounts are recorded as deferred income and included as part of creditors due within one year.

Employee benefits

Short term benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets. Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

Taxation

Current tax
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Land and buildings 50 years straight line
Plant and machinery 4 years straight line
Office equipment 25 % reducing balance

Depreciation methods, useful lives and residual values are reviewed at each balance sheet date. The selection of these residual values and estimated lives requires the exercise of judgement. The directors are required to assess whether there is an indication of impairment to the carrying value of assets. In making that assessment, judgements are made in estimating value in use. The directors consider that the individual carrying values of assets are supportable by their value in use.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

Fixed asset investments

Investments are recognised initially at fair value which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value through profit or loss if the shares are publicly traded or their fair value can otherwise be measured reliably. Other investments are measured at cost less impairment.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Equity instruments
Equity instruments issued by the Company are recorded at the fair value of cash or other resources received or receivable, net of direct issue costs. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the Company.

2. Critical accounting judgements and key sources of estimation uncertainty

The preparation of financial statements requires the use of certain critical accounting estimates. It also requires management to exercise its judgement in the process of applying the company accounting policies. The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the financial statements are disclosed within the individual accounting policies below.

3. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the year, including the director 3 2

4. Tangible assets

Land and buildings Plant and machinery Office equipment Total
£ £ £ £
Cost
At 01 November 2023 236,830 214 16,461 253,505
Additions 2,685 0 595 3,280
At 31 October 2024 239,515 214 17,056 256,785
Accumulated depreciation
At 01 November 2023 9,769 62 10,622 20,453
Charge for the financial year 4,741 54 1,565 6,360
At 31 October 2024 14,510 116 12,187 26,813
Net book value
At 31 October 2024 225,005 98 4,869 229,972
At 31 October 2023 227,061 152 5,839 233,052

5. Fixed asset investments

Other investments Total
£ £
Cost or valuation before impairment
At 01 November 2023 196,264 196,264
Additions 135,135 135,135
Disposals ( 48,784) ( 48,784)
Movement in fair value 21,591 21,591
At 31 October 2024 304,206 304,206
Carrying value at 31 October 2024 304,206 304,206
Carrying value at 31 October 2023 196,264 196,264

6. Debtors

2024 2023
£ £
Trade debtors 888,006 1,299,972
Prepayments 1,433 719
889,439 1,300,691

7. Creditors: amounts falling due within one year

2024 2023
£ £
Trade creditors 0 360
Taxation and social security 178,769 513,013
Other creditors 29,275 18,848
208,044 532,221

8. Called-up share capital

2024 2023
£ £
Allotted, called-up and fully-paid
1 Ordinary A share of £ 1.00 1 1
1 Ordinary B share of £ 1.00 1 1
1 Ordinary C share of £ 1.00 1 1
1 Ordinary D share of £ 1.00 1 1
4 4